Assessing dimensions of nicotine dependence: An evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM)
Introduction
Scientists have developed numerous theories to account for the compulsive use of drugs and alcohol despite serious consequences. These theories implicate different mechanisms of addictive motivation, such as negative reinforcement (Baker, Piper, McCarthy, Majeskie, & Fiore, 2004; Lindesmith, 1947; Wikler, 1948) , tolerance (DiChiara, 2000; Jellinek, 1960; Kalant, 1987; Perkins, 2002; Pratt, 1991) , positive reinforcement (Stewart, de Wit, & Eikelboom, 1984; Stewart & Wise, 1992) , opponentprocesses (Solomon, 1977; Solomon & Corbit, 1974) , incentive effects (Robinson & Berridge, 1993 , and social learning (Abrams & Niaura, 1987; Marlatt & Gordon, 1985) . Recently, two new measures of dependence have been developed to assess such relatively discrete dependence facets: the Nicotine Dependence Syndrome Scale (NDSS; Shiffman, Waters, & Hickcox, 2004) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM; Piper et al., 2004) . These multidimensional measures reflect a long history of research that focuses on dependence and smoking motivations, and reflect the prior work on multidimensional instruments that have assessed such motives as habitual/automatic, positive affect/indulgent, negative affect/tension reduction/sedative, addictive, stimulation, psychosocial, and sensorimotor manipulation (Best & Hakstian, 1978; Edwards, 1976 Edwards, , 1986 Ikard, Green, & Horn, 1969; McKennell, 1970; Russell, Peto, & Patel, 1974; Tate, Pomerleau, & Pomerleau, 1994; Tomkins, 1966) . Research done using these earlier instruments suggested that dependence and tobacco motivation were multifactorial and that the various factors possessed meaningful discriminative validity (Best & Hakstian, 1978; Coan, 1973; Ikard et al., 1969; Russell et al., 1974; Tate et al., 1994) .
Use of nicotine dependence measures that target specific mechanisms or dimensions of dependence are important for many reasons. For instance, scientists have become increasingly interested in characterizing relatively specific intermediate phenotypes that may be related to particular genetic variants (i.e., alleles, haplotypes). An example of this is the relation of a taste sensitivity haplotype with a dependence measure that focuses on a taste motive versus on a general feature of smoking such as number of cigarettes smoked per day (Cannon et al., 2005) . In addition, dimensional, explanatory measures might result in better characterization of smokers into discrete ''types'' or latent classes (Muthén & Asparouhov, 2006; Xian et al., 2007) .
While these new multifactorial measures of dependence were designed for research purposes, it is also possible that such measures might have clinical utility. Such measures might provide accurate prognostications of withdrawal severity or relapse likelihood. Indeed, such measures might provide predictions that are superior to those of traditional, global measures of dependence (measures intended to assess dependence per se rather than any subcomponents or types) such as the Fagerströ m Test of Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerströ m, 1991) . This could occur to the extent that the new measures are more reliable than the traditional measures, or to the extent that the discrete dimensions of dependence assessed by these measures have additive predictive validities.
Traditional measures of dependence tend to assess the end products of dependence (e.g., heavy smoking, smoking despite consequences), rather than putative mechanisms of dependence. The two main tobacco dependence assessments that are used both clinically and in research are the FTND (Heatherton et al., 1991) and the Diagnostic and Statistical Manual (4th ed.) (DSM-IV) (APA, 1994) criteria. The items from the FTND were originally designed to measure the construct of physical dependence (Schuster & Johanson, 1974) whereas the DSM-IV definition includes: ''…a cluster of cognitive, behavioral, and physiological symptoms indicating that the individual continues use of the substance despite significant substance-related problems,'' and ''…a pattern of repeated self-administration that usually results in tolerance, withdrawal, and compulsive drug-taking behavior.'' (DSM-IV, p. 176).
While these traditional measures provide relatively little insight into the nature or mechanisms of dependence, they have been shown to predict clinically important dependence criteria such as smoking heaviness and relapse (Alterman, Gariti, Cook, & Cnann, 1999; Breslau & Johnson, 2000; Campbell, Prescott, & Tjeder-Burton, 1996; Fagerströ m & Schneider, 1989; Kawakami, Takatsuka, Inaba, & Shimizu, 1999; Patten, Martin, Calfas, Lento, & Wolter, 2001; Westman, Behm, Simel, & Rose, 1997) . Therefore, they provide a meaningful benchmark with which to compare the new multidimensional measures in terms of the prediction of clinically important outcomes.
The goal of this article is to evaluate the NDSS and the WISDM in terms of their ability to predict such clinically useful dependence criteria as relapse likelihood and withdrawal severity. The NDSS (Shiffman et al., 2004 ) is a 19-item self-report measure that was developed as a multidimensional scale to assess nicotine dependence using Edwards' theory of the dependence syndrome (Edwards, 1986) . The WISDM comprises 68 items designed to assess 13 different theoretically-derived motivational domains. See Table 1 for subscale descriptions. Each measure will be evaluated based on its internal consistency and its relations with other tobacco dependence measures such as the FTND and DSM-IV, tobacco dependence criteria such as cigarettes smoked per day, and clinically important tobacco dependence criteria such as withdrawal, cessation outcome, and the rate of nicotine metabolism (which might be related to such factors as optimal nicotine replacement dosage).
Method
Data were collected from three randomized placebocontrolled smoking cessation trials. In Study 1 (n5608) participants were randomly assigned to one of the three treatment groups: active bupropion+ active 4 mg nicotine gum (AA, n5228); active bupropion SR+placebo nicotine gum (AP, n5224); or placebo bupropion SR+placebo gum (PP, n5156) (Piper et al., 2003) . All participants also received three 10-minute counseling sessions (one week prequit, on the Quit Day, and one week post-quit). In Study 2 (n5463) participants were randomly assigned to receive active bupropion+counseling (AC, n5113), active bupropion+no counseling (ANc, n5116), placebo+counseling (PC, n5121) or placebo+no counseling (PNc, n5113) in a 2 (active bupropion SR vs. placebo)62 (counseling vs. no counseling) factorial design (McCarthy, Bold, & Baker, 2007) . Counseling consisted of eight sessions of brief (10-minute) individual cessation counseling. In Study 3 (n5481) participants who provided plasma samples were randomly assigned to either a nicotine patch (n5241) or nicotine nasal spray (n5240) condition . All participants also received seven counseling sessions.
Participants
Participants were recruited through mass media in Milwaukee, WI (Study 1), Madison, WI (Study 2), Washington D.C. (Study 3) or Philadelphia, PA (Study 3) to participate in large-scale smoking cessation trials. Participants were eligible for each study if they reported smoking 10 or more cigarettes per day, were motivated to quit smoking, did not have any serious physical or mental health issues that would prevent them from participating in or completing the study, and were not pregnant or breast-feeding and took steps to prevent pregnancy during treatment. In Study 3, participants were also excluded it they had uncontrolled hypertension, unstable angina, heart attack or stroke in the last 6 months, current treatment or recent diagnosis for cancer, drug or alcohol dependence, or any use of bupropion or other nicotine-containing products other than cigarettes.
Measures
Cotinine and 3-hydroxycotinine. Nicotine is metabolized to cotinine and then to trans-39-hydroxycotinine (3-HC) by the liver enzyme cytochrome P450 (CYP) 2A6 (Nakajima et al., 1996) . The ratio of 3-HC to cotinine is an index of the rate of nicotine metabolism which provides a phenotypic measure of CYP 2A6 activity and, in some studies, is correlated with number of cigarettes smoked per day (Benowitz, Pomerleau, Pomerleau, & Jacob, 2003; Dempsey et al., 2004; Malaiyandi et al., 2006) . This ratio has also been shown to predict smoking cessation following nicotine patch therapy . Assays of cotinine and 3-HC were performed on blood samples collected at baseline in Study 3 only.
Demographics and smoking history. These questionnaires (the same for Studies 1 and 2 and different for Study 3) assessed characteristics such as gender, ethnicity, age, marital status, education level, and employment. The smoking history questionnaire included items such as the number of cigarettes smoked per day, age of smoking initiation, smoking status (e.g., daily smoker, occasional smoker, etc.), number of quit attempts, longest time abstinent, and other smokers in the household.
Fagerström Test of Nicotine Dependence (FTND).
The FTND is a 6-item scale designed to measure tobacco dependence. Each item has its own individual response scale and previous research indicates that it has fair internal consistency (a5.61) (Heatherton, et al., 1991) .
Nicotine Dependence Syndrome Scale (NDSS).
The NDSS is a 19-item self-report measure comprising five theoretically-derived subscales (see Table 1 ) (Shiffman et al., 2004) . Each item is rated on a 5-point Likert scale from 15''Not at all true'' to 55''Extremely true.'' This measure is scored using factor loadings. To calculate an individual's score on each subscale and on the total NDSS, the researcher must multiply the participant's answer to each question by the specific factor loading provided by Shiffman et al. (2004) and then sum each factoradjusted answer relevant to the subscale being calculated. Some items are reversed scored and have negative factor loadings. In addition, a number of items load on multiple subscales but they may have positive loadings on some subscales and negative loadings on other subscales. The total NDSS does not include all 19 items used in the subscales. The NDSS was not administered in Study 3.
Tobacco Dependence Screener (TDS). The TDS is a self-report measure designed to assess 10 DSM-IV tobacco dependence criteria, with ''0'' indicating lack of the symptom and ''1'' indicating endorsement of the criterion. Research shows the TDS has good internal consistency (a5.76-.81 across three studies) (Kawakami, et al., 1999) . The TDS was not administered in Study 3.
Wisconsin Inventory of Smoking Dependence Motives (WISDM). The WISDM comprises 68 items designed to assess 13 different theoretically-derived motivational domains (see Table 1 ) on a 7-point Likert scale ranging from 15''Not true of me at all'' to 75''Extremely true of me'' . Subscales are scored by taking the average of all of the answers relevant to that subscale. Only ''Craving,'' ''Cue exposure/Associative processes,'' ''Negative reinforcement,'' ''Positive reinforcement,'' and ''Tolerance'' were administered in Study 3, to a subset of participants, because the WISDM scales were added after the study had already begun.
Procedure
In all three studies, eligible participants were invited to an orientation session where they were told about the study, and asked to provide written informed consent along with demographic and smoking history information, including a carbon monoxide breath test (excluded if CO,10 ppm). Participants also completed the multiple tobacco dependence measures described above. Participants were contacted at 6-months post-quit. At this time, all participants who reported abstinence for the previous 7 days were scheduled to return to the clinic and provide a breath sample for CO analysis.
Participants in Studies 1 and 2 also provided ecological momentary assessment (EMA) data about their smoking, stressors, withdrawal symptoms (e.g., desire to smoke, difficulty concentrating, sadness, irritability), and other life events. In Study 1, participants carried cellular phones for 2 weeks, centered around the Quit Day, and responded to four calls: one after waking, one before going to bed, and two other prompts that occurred randomly during the day. Eleven items from the Wisconsin Smokers Withdrawal Scale (WSWS) (Welsch et al., 1999) , answered on a 1 to 5 Likert scale (15''disagree'' and 55''agree''), were used in Study 1 to assess craving, hunger, negative affect, and difficulty concentrating within the last 30 minutes. Data from all four calls were aggregated to summarize withdrawal during each day. In Study 2, participants carried electronic diaries for 2 weeks pre-quit and 4 weeks post-quit and responded to at least six alarms per day (one upon waking, one prior to going to bed, and four or more random prompts). In Study 2, 20 items from the WSWS, answered on a 1 to 11 Likert scale (15''low'' and 115''high'') were used to assess craving, hunger, negative affect, and difficulty concentrating. From Study 2, only the evening report data (collected before going to bed) was used in the withdrawal calculations, because the time frames for the morning and evening reports were different from the time frames for the random prompts, and use of the evening report data provided the only comprehensive assessment of withdrawal across the entire day.
Analytic methods
Data for all analyses are based on data pooled across Study 1 and Study 2, unless otherwise noted. The same pattern of results was found for both individual studies unless otherwise noted. Data from Study 3 were used solely to examine the relation of the scales with the log of the ratio of 3-HC to cotinine. The log of the ratio was taken to create a normally distributed independent variable and has been shown to be the optimal measure for estimating clearance (Levi et al., 2007) . All analyses were conducted using SPSS 14.0 for Windows (SPSS, Inc., 2006) unless otherwise noted. Both Bonferroni corrected and uncorrected p values are supplied for the multiple validation analyses. Hierarchical Linear Modeling (HLM) (Scientific Software International, 2001 ) software was used to analyze increase in withdrawal on the quit day and over the first week post-quit. Data from all participants were included in the analyses, regardless of smoking status, because previous research suggests that eliminating lapsers from analyses inappropriately constrains withdrawal relations (Piasecki, Jorenby, Smith, Fiore, & Baker, 2003a) . Best-fitting models to predict cessation outcome were created using Hosmer and Lemeshow's (2000) model-building criteria.
Results

Participant characteristics
The combined sample from Study 1 and Study 2 comprised 1,071 smokers (54.6% women; see Table 2 for demographic information). While the two study samples were comparable, there were statistically although some of these differences were relatively modest (e.g., mean age difference 3.02 years, mean CO difference 2.6 ppm). Thus, the combined sample comprised a more diverse population than did the individual samples. Participants in Study 3 were 54.7 % women and 28.3% Black (Table 2) .
Dependence scores and general psychometrics
Means and standard deviations were calculated for all of the dependence scales for the total sample, men, women, White smokers and Black smokers (Table 3) . Only 29 individuals (2.8%) identified themselves as neither White nor Black and were not included in analyses of race. Results indicated that men and women differed on several subscales, as did White and Black smokers (Table 3) . However, analyses showed that neither gender nor race interacted significantly with nicotine dependence scale and subscale scores in the prediction of dependence criteria.
Psychometric analyses revealed that the NDSS subscales had rather poor internal consistencies (using the factor-scaled scores for all items; a5.30-.59). (When only the three highest loading items on each factor were used in the internal consistency analysis (Shiffman et al., 2004) , results revealed a5.26-.65. These relatively low internal consistency estimates may be attributed in part to the fact that the sample was comprised of treatment seekers and this may have restricted the range of NDSS scores.) However, the overall measure had acceptable internal consistency (a5.79). The WISDM subscales all demonstrated acceptable to good internal consistency (a5.74-.94), as did the total WISDM (a5.96). See Table 1 for results. These internal consistency estimates were consistent for men, women, White, and Black participants (data not shown).
Convergent and concurrent validity
To assess the validity of the NDSS and WISDM, their relations with established tobacco dependence measures (i.e., FTND and TDS) and with specific tobacco dependence criteria (i.e., cigarettes smoked per day, CO, and cessation outcome) were examined both at the subscale and total score levels. Correlation analyses revealed that almost all of the NDSS and WISDM subscales were statistically significantly related to both the FTND and TDS, With respect to concurrent validity, the number of cigarettes smoked per day was statistically significantly related to all scales, with the exception of WISDM Weight Control. Again, the magnitude of the correlations ranged from modest to moderate (see Table 1 ). In terms of the multifactorial measures, the NDSS Total and WISDM Tolerance scales had the strongest correlation with cigarettes smoked per day (r5.35 and .43, p values (.002, respectively). The strongest correlation across all scales with daily cigarette consumption was obtained for the FTND (r5.54), which reflects the fact that the FTND directly assessed number of cigarettes smoked each day. There were fewer statistically significant relationships between the dependence measures and CO (Table 1) . Among the NDSS and WISDM subscales, the WISDM Tolerance subscale provided the strongest prediction of CO, but even this was modest (r5.28) and the FTND had the strongest relation (r5.34).
Finally, correlation analyses revealed that the log of the 3-HC to cotinine ratio was modestly related to number of cigarettes smoked per day (n5476, r5.12, p5.01), the WISDM Craving subscale (n5354, r5.13, p5.02) and the WISDM Cue Exposure/ Associative Processes subscale (n5354, r5.11, p5.05). Thus, the data suggest that individuals with faster metabolism tended to smoke more and reported that they were more likely to smoke due to cravings and smoking cues. However, these effects are quite modest and the p values do not exceed the Bonferroni alpha correction which results in p,.007 for the seven correlations computed in Study 3. The other candidate predictors tested, WISDM Negative Reinforcement, WISDM Positive Reinforcement, WISDM Tolerance and FTND, shared even weaker relations with nicotine metabolism. Study 3 did not administer the NDSS.
Predictive validity -withdrawal
Next, we examined the ability of the NDSS and WISDM subscales to predict two different aspects of withdrawal: the change in withdrawal symptoms on the quit day and the post-quit slope, or change in withdrawal over the first week post-quit. For this purpose, we fit two-level hierarchical linear models in which a random intercept (interpretable as change in withdrawal symptoms on the quit day) and slope (interpretable as average daily change in withdrawal symptoms post-quit) were determined for each individual using Empirical Bayes estimates (Piper et al., 2008) . Models allowed for random error and did not use cigarette smoking as a time-varying covariate since previous analyses with these data revealed that withdrawal symptoms are very modestly related to such smoking (Piper et al., 2008) . Data from Study 1 and Study 2 were analyzed separately due to their different metrics for measuring withdrawal. Results revealed that, after controlling for treatment, the NDSS Drive and WISDM Negative Reinforcement scales showed the strongest relations with the Empirical Bayes estimates of change in withdrawal on the quit day in both studies ( Table 1) . Neither of these effects was statistically significant following Bonferroni correction. In general, the magnitude of predicted relations was modest, with NDSS Drive accounting for approximately 1.4% to 4.2% of the variance, and WISDM Negative Reinforcement accounting for approximately 1.0% to 1.3% of the variance, in change in withdrawal on the quit day relative to treatment, accounting for approximately 0.5% to 3.6% of the variance in change in withdrawal on the quit day across the two studies. It is important to note that the relative magnitude of HLM coefficients across the two studies is also influenced by the different units of measurement in the withdrawal assessment. No subscales were significant predictors of the change in withdrawal symptoms over time, and there were no consistent predictors of change in craving on the quit day or post-quit slope in craving across the two studies. The FTND was not related to either withdrawal or craving dimensions.
Predictive validity -cessation outcome
Logistic regression analyses suggested that few dependence scales or subscales were related to smoking at the three time points assessed (1 week post-quit, end of treatment/8 weeks post-quit, and 6 months post-quit) after controlling for treatment and study (Table 1) . Treatment was coded as ''1'' for individuals who received active bupropion and ''0'' for those who did not. We did not code for use of nicotine gum in Study 1, given that it did not have a statistically significant effect on outcome (Piper et al., 2008 ) nor did we code for counseling effects in Study 2, for similar reasons (McCarthy et al, in press ). Study was used as a control variable because participants in Study 1 were significantly more likely to be abstinent at 1 week and end of treatment than were participants in Study 2 (data not shown). The NDSS Total and the NDSS Priority subscale significantly predicted abstinence across all three time points, with odds ratios ranging from 1.21 to 1.28 for Priority and 1.17 to 1.23 for NDSS Total. Only two WISDM subscales predicted abstinence at all three time points (''Automaticity'' and ''Tolerance''), with odds ratios ranging from 1.10 to 1.15 and 1.15 to 1.24 respectively.
Best-fitting models were created for the NDSS, the WISDM and for a combined NDSS/WISDM model for each follow-up time point, controlling for treatment and study (Table 4) . Results revealed that WISDM Tolerance predicted abstinence at each time point but that its prediction of early abstinence (at 1 week post-quit and end of treatment) was augmented by Social/Environmental Goads (Table 4) . Amongst NDSS subscales, ''Priority'' was the only consistent predictor of outcome at each time point and was augmented by the Stereotypy subscale in predicting outcome at 1 week post-quit. Results also showed that when the WISDM and NDSS subscales were entered simultaneously, only the WISDM Tolerance and Social/Environmental Goads subscales were retained in the best-fitting model of smoking at 1 week post-quit. The best-fitting model predicting smoking at the end of treatment contained the NDSS Priority and the WISDM Social/Environmental Goads subscales, and the best-fitting model predicting smoking at 6 months post-quit contained the NDSS Priority and WISDM Tolerance subscales.
To determine whether the FTND could improve on prediction of outcome for the NDSS, WISDM and combined models, we entered FTND score as a third step in a hierarchical regression analysis, after controlling for treatment and study. Results revealed that for models predicting outcome at 1 week and the end of treatment, adding the FTND resulted in a significant improvement in model fit, based on the step chi-square (x 2 56.28 to 25.82, p5.01 to ,.001). However, at 6 months post-quit, adding the FTND improved prediction of the NDSS model (x 2 510.20, p5.001), but did not improve prediction of the WISDM or the combined NDSS/WISDM models. We also examined whether the NDSS and WISDM subscales could improve on the ability of the FTND to predict cessation outcome. Results revealed that adding the best NDSS/WISDM model as a second step in a hierarchical regression analysis improved prediction, based on the step chi-square, at the end of treatment (x 2 514.50, p,.01) but the NDSS/WISDM model did not significantly improve prediction at 1 week (x 2 53.58, p5.17) or 6 months (x 2 55.17, p5.08) post-quit.
Data were also analyzed to examine the performance of these best-fitting models in men and women and White and Black smokers (there was insufficient power to analyze any other racial/ethnic group). There were no statistically significant differences in the performance of these models in Table 4 . Best fitting models for predicting smoking after controlling for treatment and study. predicting outcome for either gender or racial/ethnic group when gender/ethnicity and scale by gender/ ethnicity interactions were included in the model. However, it should be noted that there were only 155 Black smokers in this sample, so power may not have been sufficient to detect a significant effect.
Discussion
The present research describes the ability of current tobacco dependence measures to assess such clinically important outcomes as withdrawal and cessation. The data suggest that in order to achieve optimal prediction of these important outcomes, one needs to use different scales to achieve the best overall prediction. Thus, this research extends to the newer multifactorial instruments a conclusion drawn from research on the traditional dependence instruments: viz. none of the dependence instruments predicts outcomes well across all major dependence criteria (abstinence, self-administration heaviness, and withdrawal severity) (Piper, McCarthy, & Baker, 2006) . It is clear from the examination of the results that the FTND tends to yield better prediction of cessation outcomes than any other single scale or subscale. Adding the FTND to the WISDM and NDSS models improved model fit at 1 week and end of treatment. However, the FTND did not improve prediction over the WISDM and the combined NDSS/WISDM models at 6 months post-quit. Conversely, adding the best NDSS/WISDM scales to the FTND resulted in improved prediction only at the end of treatment. While the FTND may be the best predictor of cessation outcome, the use of the multidimensional scales may provide some insight into the motivations that influence relapse, such as the density of smoking cues in the environment predicting early cessation success.
The chief value of the NDSS and WISDM may be that they permit assessment of particular motivational influences on smoking and may be more sensitive to particular smoking motives or in subpopulations. The different patterns of relations of scales with criteria may suggest different causal influences on smoking features or outcomes, a notion that has been studied for more than 40 years among researchers of smoking motivations (Best & Hakstian, 1978; Ikard et al., 1969; McKennell, 1970; Russell et al., 1974; Tate et al., 1994; Tomkins, 1966) . In the present research, the scales that had the highest relations with withdrawal (NDSS Drive and WISDM Negative Reinforcement) were different from those that were most highly predictive of cessation outcome (NDSS Priority, WISDM Automaticity and Tolerance). In addition, the WISDM Craving and Cue Exposure subscales were relatively highly related to individual rate of nicotine metabolism, although the relations observed were still of small magnitude and did not meet our conservative criterion for statistical significance. Thus, the increase in withdrawal symptoms on the quit day was related to selfreported need for cigarettes to control cravings and influence affect, while smoking at follow-up was related to a pattern of self-reported heavy and constant smoking that occurred outside of conscious control (i.e. automatically) (Transdisciplinary Tobacco Use Research Center [TTURC] Nicotine Dependence Phenotype Working Group, 2007) . The fact that the different subscales had varying patterns of relations with validation measures suggests that a single facet of tobacco dependence cannot optimally predict outcomes across all of the dependence criteria (e.g., heaviness of smoking, withdrawal, relapse risk) (Pomerleau et al., 2005) . Furthermore, scales that are intended to assess the same construct (i.e., the WISDM and NDSS Tolerance scales) may have different predictive relations if they approach the construct in different ways. For instance, the WISDM Tolerance items focus on being a ''heavy'' smoker and needing to smoke after periods of abstinence (e.g., overnight) whereas the NDSS focuses more on assessing the effects of smoking, including both the need to smoke more to achieve the same subjective effects and the ability to smoke more without experiencing the negative effects. The different foci of these two assessments of the Tolerance construct might suggest which elements are more implicated in dependence. In other words, it appears that self-reported heavy smoking and the need to smoke after deprivation are more strongly related to cessation outcome than is the self-report of the positive and negative drug effects.
An example of how multidimensional measures might shed light on differences across subpopulations of smokers comes from analyses contrasting the performance of men and women on the different scales. While traditional measures of nicotine dependence end states, such as the FTND and TDS, do show significant gender differences, they do not implicate particular dependence features in these differences. The NDSS and WISDM, however, are informative because of the pattern of gender differences across the various subscales (Table 3) . Specifically, results suggest that women tend to score higher on scales that reflect the impact of environmental cues and smoking to control negative moods and weight. These findings are consistent with prior data that indicate that smoking may be more cuedependent among women than men, and that control of negative affect may be a more salient goal for women (Perkins, Donny, & Caggiula,1999; Perkins et al., 2001; Wetter et al., 1994) . In comparison, men earned higher scores on the NDSS Continuity and NDSS Stereotypy subscales, indicating that men report a greater tendency to smoke continuously or regularly across time and place. In theory, such findings might allow researchers to develop treatments that are better tailored to each sex. Although absolute levels of abstinence outcomes might be the same, it is possible that different dependence subtypes or motives might reflect different vulnerabilities or sensitivities that might ultimately end in a return to smoking. However, it is important to note that despite these differences in dependence motivations, there were no gender-by-scale interactions in the prediction of cessation outcome.
Another insight offered by this research is the possible link between cigarettes smoked per day, the WISDM Craving and WISDM Cue Exposure subscales, and the rate of nicotine metabolism, suggesting that individuals who quickly metabolize nicotine are more likely to be heavier smokers, may smoke more in response to cravings, and may be more influenced by smoking-related cues (see also Lerman et al., 2006; Malaiyandi et al., 2006) . This tentative observation, combined with the finding that individuals with high WISDM Craving scores were more likely to have more severe withdrawal, suggests that individuals who are faster metabolizers of nicotine need to smoke more to maintain sufficient central nervous system levels of nicotine in their systems and may be more sensitive to both interoceptive and exteroceptive cues to maintain high nicotine levels in the body . Furthermore, more rapid metabolism means that nicotine levels in the blood and brain decline more quickly after smoking a cigarette, which could explain more severe withdrawal symptoms, including more craving. However, as noted earlier, such findings were of modest size and require replication. There are limitations, both with respect to the new multidimensional measures, and with the research in general. First, some subscales have modest internal consistencies (e.g., the NDSS Tolerance and Continuity subscales) and this may explain why these subscales were not more highly related to other measures. Second, although these multidimensional measures may shed light on the nature of nicotine dependence, neither the NDSS nor the WISDM measures do as good a job of predicting cessation outcome as does the FTND. However, there was evidence that optimal combination of subscales have the potential to yield abstinence outcome predictions that are superior to those yielded by the FTND. Further research is needed to extend and replicate these findings.
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